Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer
| Image |  |
|---|---|
| Description | scientific article published on 19 October 2017 |
| Author/s |
author: Funda Meric-Bernstam Siqing Fu Sarina Piha-Paul Filip Janku Apostolia Maria Tsimberidou |
| Publication date | October 19, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |